Synthesis and biological activity

Medicinal chemists working on synthesis and biological activity design small organic molecules—often built around ring-containing frameworks called heterocycles—and then test how those structures interact with specific biological targets linked to disease. Compounds such as chalcones, coumarins, and pyrazoles have drawn sustained attention because subtle changes to their ring systems or substituents can dramatically shift potency, selectivity, and toxicity profiles, particularly against cancer cells where disrupting proteins like tubulin can halt tumor growth or collapse the blood vessels that feed it. A central challenge is translating promising in-vitro activity into drug candidates that remain effective and safe in living systems, which requires understanding not just what a compound does but why its three-dimensional shape enables it to do so. Ongoing work is pushing toward rational, structure-guided design and the exploration of hybrid molecules that combine two pharmacophores in a single scaffold, aiming to overcome the resistance mechanisms that limit existing anticancer therapies.

Works

99,462

Total citations

930,629

Keywords

Heterocyclic CompoundsMedicinal ChemistryAnticancer AgentsTubulin InhibitorsVascular Targeting AgentsChalcones